These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4822497)

  • 21. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.
    Parkinson D; Callingham BA
    J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1973 Nov; 187(2):365-71. PubMed ID: 4748552
    [No Abstract]   [Full Text] [Related]  

  • 23. Spontaneous peripheral leakage of pargyline on intracerebroventricular administration.
    Ali B; Parmar SS; Seth PK; Brumleve SJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1083-6. PubMed ID: 4760882
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoamine oxidase-III. Further studies of inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and pharmacology of a pargyline analog, N-3-(1-butynyl)-benzylamine.
    Siuda JF; Cihonski C; Sofia RD; Buckley JP
    J Pharm Sci; 1973 Feb; 62(2):331-2. PubMed ID: 4686418
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of radiorespirometry for the determination of monoamine oxidase activity in vivo utilizing [11C]octylamine as a substrate.
    Gallagher BM; Fowler JS; MacGregor RR; Wolf AP
    Biochem Pharmacol; 1977 Oct; 26(20):1917-22. PubMed ID: 911345
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis of ubiquitin-dependent regulation of the monoamine oxidase sensitivity to proteolysis and specific inhibition by pargyline].
    Buneeva OA; Medvedeva MV; Medvedev AE
    Biomed Khim; 2008; 54(6):720-6. PubMed ID: 19205432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification and properties of mitochondrial monoamine oxidase in beef brain.
    Harada M; Mizutani K; Nagatsu T
    J Neurochem; 1971 Apr; 18(4):559-69. PubMed ID: 5581571
    [No Abstract]   [Full Text] [Related]  

  • 31. Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.
    Efange SM; Michelson RH; Remmel RP; Boudreau RJ; Dutta AK; Freshler A
    J Med Chem; 1990 Dec; 33(12):3133-8. PubMed ID: 2258899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple forms of mitochondrial monoamine oxidase.
    Diaz Borges JM; D'Iorio A
    Adv Biochem Psychopharmacol; 1972; 5():79-89. PubMed ID: 4559892
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 34. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F; Youdim MB; Agid Y; Glowinski J
    J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
    [No Abstract]   [Full Text] [Related]  

  • 35. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.
    Boudíková-Girard B; Scott MC; Weinshilboum R
    Agents Actions; 1993 Sep; 40(1-2):1-10. PubMed ID: 8147263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The monoamine oxidase inhibitory effect of new homopyrimidazole derivatives.
    Magyar K; Satory E; Meszaros Z
    Med Biol; 1974 Dec; 52(6):384-9. PubMed ID: 4444359
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability and purification of lysyl oxidase.
    Narayanan AS; Siegel RC; Martin GR
    Arch Biochem Biophys; 1974 May; 162(1):231-7. PubMed ID: 4857532
    [No Abstract]   [Full Text] [Related]  

  • 38. The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavine of mitochondrial amine oxidase.
    Maycock AL; Abeles RH; Salach JI; Singer TP
    Biochemistry; 1976 Jan; 15(1):114-25. PubMed ID: 2278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of rat brain mitochondrial monoamine oxidase.
    Youdim MB
    Adv Biochem Psychopharmacol; 1974; 11(0):59-63. PubMed ID: 4136105
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of soluble and particulate amine oxidases from bovine aorta.
    Harris ED; O'Dell BL
    Biochem Biophys Res Commun; 1972 Sep; 48(5):1173-8. PubMed ID: 5054751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.